![Sally Dewhurst](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sally Dewhurst
Director/Miembro de la Junta en Grey Wolf Therapeutics Ltd. .
Cargos activos de Sally Dewhurst
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Grey Wolf Therapeutics Ltd.
![]() Grey Wolf Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Grey Wolf Therapeutics Ltd. is a biotechnology company, which engages in the drug discovery in immuno-oncology. It targets endoplasmic reticulum aminopeptidases 1 and 2 in the antigen presentation pathway to drive modulation of the neoantigen repertoire on tumour cells. The company was founded by Thomas D. McCarthy and Peter Joyce and is headquartered in Oxford, the United Kingdom. | Director/Miembro de la Junta | 24/01/2023 | - |
Oxford Science Enterprises PLC
![]() Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom. | Inversor de Capital Privado | 01/07/2023 | - |
Alethiomics Ltd.
![]() Alethiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Alethiomics Ltd. operates as a British biotechnology company. The company is based in Cambridge, UK. The company was founded in 2021 by Adam Joseph Mead, Bethan Psaila. The CEO is Mark Throsby. | Director/Miembro de la Junta | 01/11/2022 | - |
Historial de carrera de Sally Dewhurst
Antiguos cargos conocidos de Sally Dewhurst.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
DJS Antibodies Ltd.
![]() DJS Antibodies Ltd. BiotechnologyHealth Technology DJS Antibodies Ltd. designs and discovers novel therapeutic monoclonal antibodies against G-protein-coupled receptors. The firm conducts discovery against three targets in the fields of oncology, fibrosis and vascular disease. The company was founded by David Colin Conway Llewellyn and Joseph James Illingworth and is headquartered in Bicester, the United Kingdom. | Corporate Officer/Principal | 01/09/2021 | 01/10/2022 |
Formación de Sally Dewhurst.
University of Durham | Graduate Degree |
Estadísticas
Internacional
Reino Unido | 6 |
Operativa
Director/Board Member | 2 |
Private Equity Investor | 1 |
Graduate Degree | 1 |
Sectorial
Health Technology | 3 |
Finance | 2 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 4 |
---|---|
Grey Wolf Therapeutics Ltd.
![]() Grey Wolf Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Grey Wolf Therapeutics Ltd. is a biotechnology company, which engages in the drug discovery in immuno-oncology. It targets endoplasmic reticulum aminopeptidases 1 and 2 in the antigen presentation pathway to drive modulation of the neoantigen repertoire on tumour cells. The company was founded by Thomas D. McCarthy and Peter Joyce and is headquartered in Oxford, the United Kingdom. | Health Technology |
Oxford Science Enterprises PLC
![]() Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom. | Finance |
Alethiomics Ltd.
![]() Alethiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Alethiomics Ltd. operates as a British biotechnology company. The company is based in Cambridge, UK. The company was founded in 2021 by Adam Joseph Mead, Bethan Psaila. The CEO is Mark Throsby. | Commercial Services |
DJS Antibodies Ltd.
![]() DJS Antibodies Ltd. BiotechnologyHealth Technology DJS Antibodies Ltd. designs and discovers novel therapeutic monoclonal antibodies against G-protein-coupled receptors. The firm conducts discovery against three targets in the fields of oncology, fibrosis and vascular disease. The company was founded by David Colin Conway Llewellyn and Joseph James Illingworth and is headquartered in Bicester, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Sally Dewhurst
- Experiencia